Results 181 to 190 of about 39,275 (210)

GLP-1 receptor agonists and suicidality

BMJ
Peter, Ueda, Björn, Pasternak
openaire   +2 more sources

GLP-1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes

Journal of the American College of Cardiology, 2023
João S Neves, Marta Borges-Canha, Stefano Del Prato   +2 more
exaly  

The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes

Cell Metabolism, 2017
Juan Frias, Christophe Schmitt, Richard D Dimarchi   +2 more
exaly  

Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis

Cell Reports, 2020
Tito Borner, Samantha M Fortin, Lauren M Stein   +2 more
exaly  

GLP-1 Receptor Agonists Help Legs

Diabetes Care
Ronald M. Goldenberg, Subodh Verma
openaire   +2 more sources

Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial

Lancet, The, 2018
Juan Frias, Michael A Nauck, Shweta Urva
exaly  

Safety and Efficacy of Dulaglutide, a Once Weekly GLP-1 Receptor Agonist, for the Management of Type 2 Diabetes

Postgraduate Medicine, 2014
Guillermo E Umpierrez, Cde, Leonardo Mancillas-Adame, Laura Fernández Landó   +2 more
exaly  

Crystal structure of the GLP-1 receptor bound to a peptide agonist

Nature, 2017
Nathan Robertson, Miles Congreve, Andrea Bortolato   +2 more
exaly  

Systemic Allergic Reaction to the GLP-1 Receptor Agonist Exenatide

Journal of Pharmacy Technology, 2014
Esther Helen Steveling-Klein, Bettina Winzeler, Andreas J Bircher   +2 more
exaly  

Coprescribing GLP-1 Receptor Agonists and Lifestyle

JAMA Internal Medicine
Michelle S, Rockwell, Elizabeth A, Polk, Camille, Mittendorf   +2 more
openaire   +2 more sources